Number needed to treat in COPD: exacerbations versus pneumonias (Q38057718)

27 August 2017

Number needed to treat in COPD: exacerbations versus pneumonias. (English)

1 reference

27 August 2017

0 references

Samy Suissa

1

1 reference

PubMed ID

23125170

27 August 2017

language of work or name

English

0 references

publication date

2 November 2012

1 reference

27 August 2017

1 reference

27 August 2017

68

1 reference

27 August 2017

6

1 reference

27 August 2017

540-543

1 reference

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

27 August 2017

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202709

Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202709

Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202709

The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202709

Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202709

Effect of fluticasone propionate/salmeterol (250/50) on COPD exacerbations and impact on patient outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202709

Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202709

Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202709

Reported pneumonia in patients with COPD: findings from the INSPIRE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202709

An assessment of clinically useful measures of the consequences of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202709

Evaluating the effectiveness of combination therapy to prevent COPD exacerbations: the value of NNT analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202709

Exaggeration of treatment benefits using the "event-based" number needed to treat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202709

Calculation of number needed to treat

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202709

Number needed to treat is incorrect without proper time-related considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202709

The "number needed to treat" turns 20--and continues to be used and misused

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202709

Calculating the number needed to treat for trials where the outcome is time to an event

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202709

Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202709

Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202709

10.1136/THORAXJNL-2012-202709

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference

PubMed ID

23125170